Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH)

Reinhold Munker; Mary Lowery Nordberg; Diana Veillon; B. Jill Williams; Anthony Roggero; Wolfgang Kern; Frank Dicker; Torsten Haferlach

doi:10.1016/j.leukres.2009.04.008

Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH)

Reinhold Munker
, Mary Lowery Nordberg
, Diana Veillon
, B. Jill Williams
, Anthony Roggero
, Wolfgang Kern
, Frank Dicker
, Torsten Haferlach

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

A new myeloid leukemia cell line (CG-SH) with normal cytogenetics was established from a patient with acute myelogenous leukemia (AML) following myelodysplastic syndrome (MDS). The cells of CG-SH are immature blasts and have an immature myeloid phenotype (positive for myeloperoxidase, CD7, CD34, CD38, CD117, HLA-DR, negative for CD10, CD19, CD20, CD41, CD42). A partial expression of CD13, CD15, CD65 and a weak expression of CD33 and CD133 was noted. The cells are negative for EBER. By molecular analysis, a mutation of NRAS and heterozygous mutations of RUNX1 were detected. No mutations were detected in FLT3-ITD, MLL-PTD or NPM1. By real-time PCR, a series of 19 microRNAs was identified which are strongly expressed in CG-SH. In conclusion, a new cell line was established which will be useful for the study of AML with normal cytogenetics and mutations in NRAS and/or RUNX1.

Original language	English
Pages (from-to)	1405-1408
Number of pages	4
Journal	Leukemia Research
Volume	33
Issue number	10
DOIs	https://doi.org/10.1016/j.leukres.2009.04.008
State	Published - Oct 2009

Funding

The authors thank Dr. Kevin Dowden for a photomicrograph, Cory (Joseph) Cordova and Paula Polk for technical assistance, the Feist Weiller Cancer Center for financial support and Drs. Shari Meyers and Jonathan Glass for critical comments.

Funders
LSUHSC-Feist Weiller Cancer Center, Shreveport

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

AML
Cell line
Normal cytogenetics

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2009.04.008

Cite this

@article{2d90ec25d5684b42a78b9c8c206e2df7,

title = "Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH)",

abstract = "A new myeloid leukemia cell line (CG-SH) with normal cytogenetics was established from a patient with acute myelogenous leukemia (AML) following myelodysplastic syndrome (MDS). The cells of CG-SH are immature blasts and have an immature myeloid phenotype (positive for myeloperoxidase, CD7, CD34, CD38, CD117, HLA-DR, negative for CD10, CD19, CD20, CD41, CD42). A partial expression of CD13, CD15, CD65 and a weak expression of CD33 and CD133 was noted. The cells are negative for EBER. By molecular analysis, a mutation of NRAS and heterozygous mutations of RUNX1 were detected. No mutations were detected in FLT3-ITD, MLL-PTD or NPM1. By real-time PCR, a series of 19 microRNAs was identified which are strongly expressed in CG-SH. In conclusion, a new cell line was established which will be useful for the study of AML with normal cytogenetics and mutations in NRAS and/or RUNX1.",

keywords = "AML, Cell line, Normal cytogenetics",

author = "Reinhold Munker and Nordberg, \{Mary Lowery\} and Diana Veillon and Williams, \{B. Jill\} and Anthony Roggero and Wolfgang Kern and Frank Dicker and Torsten Haferlach",

year = "2009",

month = oct,

doi = "10.1016/j.leukres.2009.04.008",

language = "English",

volume = "33",

pages = "1405--1408",

number = "10",

}

TY - JOUR

T1 - Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH)

AU - Munker, Reinhold

AU - Nordberg, Mary Lowery

AU - Veillon, Diana

AU - Williams, B. Jill

AU - Roggero, Anthony

AU - Kern, Wolfgang

AU - Dicker, Frank

AU - Haferlach, Torsten

PY - 2009/10

Y1 - 2009/10

N2 - A new myeloid leukemia cell line (CG-SH) with normal cytogenetics was established from a patient with acute myelogenous leukemia (AML) following myelodysplastic syndrome (MDS). The cells of CG-SH are immature blasts and have an immature myeloid phenotype (positive for myeloperoxidase, CD7, CD34, CD38, CD117, HLA-DR, negative for CD10, CD19, CD20, CD41, CD42). A partial expression of CD13, CD15, CD65 and a weak expression of CD33 and CD133 was noted. The cells are negative for EBER. By molecular analysis, a mutation of NRAS and heterozygous mutations of RUNX1 were detected. No mutations were detected in FLT3-ITD, MLL-PTD or NPM1. By real-time PCR, a series of 19 microRNAs was identified which are strongly expressed in CG-SH. In conclusion, a new cell line was established which will be useful for the study of AML with normal cytogenetics and mutations in NRAS and/or RUNX1.

AB - A new myeloid leukemia cell line (CG-SH) with normal cytogenetics was established from a patient with acute myelogenous leukemia (AML) following myelodysplastic syndrome (MDS). The cells of CG-SH are immature blasts and have an immature myeloid phenotype (positive for myeloperoxidase, CD7, CD34, CD38, CD117, HLA-DR, negative for CD10, CD19, CD20, CD41, CD42). A partial expression of CD13, CD15, CD65 and a weak expression of CD33 and CD133 was noted. The cells are negative for EBER. By molecular analysis, a mutation of NRAS and heterozygous mutations of RUNX1 were detected. No mutations were detected in FLT3-ITD, MLL-PTD or NPM1. By real-time PCR, a series of 19 microRNAs was identified which are strongly expressed in CG-SH. In conclusion, a new cell line was established which will be useful for the study of AML with normal cytogenetics and mutations in NRAS and/or RUNX1.

KW - AML

KW - Cell line

KW - Normal cytogenetics

UR - https://www.scopus.com/pages/publications/67649311629

UR - https://www.scopus.com/pages/publications/67649311629#tab=citedBy

U2 - 10.1016/j.leukres.2009.04.008

DO - 10.1016/j.leukres.2009.04.008

M3 - Article

C2 - 19414191

AN - SCOPUS:67649311629

SN - 0145-2126

VL - 33

SP - 1405

EP - 1408

JO - Leukemia Research

JF - Leukemia Research

IS - 10

ER -

Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH)

Abstract

Funding

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this